Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
UK’s ageing nuclear fleet offers target for China’s atomic tech

2018-07-10 thestar.com.my
HONG KONG: The possible replacement of the UK’s ageing nuclear reactor fleet may offer China’s ambitious atomic power companies an outlet for investment and technology.
MQBKY DSECF 8601 DSEEY MCQEF MQG

0
U.K.'s Aging Nuclear Fleet Offers Target for China Ambitions - Bloomberg

2018-07-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
MQBKY DSECF 8601 DSEEY MCQEF MQG

0
StarHub’s new CEO takes over one of Singapore’s worst-performing stocks

2018-07-03 theedgemarkets
(July 3): After plunging about 42% this year, StarHub Ltd shares may be set for a modest turnaround, just as incoming Chief Executive Officer Peter Kaliaropoulos takes over next week.
DBSDY D05 TPGTF DBSDF TPPTY DSECF 8601 SRHBF TPM NFLX DSEEY SRHBY

16
StarHub’s new CEO takes over one of Singapore’s worst-performing stocks

2018-07-03 malaymail
SINGAPORE, July 3 — After plunging about 42 per cent this year, StarHub Ltd shares may be set for a modest turnaround, just as incoming Chief Executive Officer Peter Kaliaropoulos takes over next week.
DBSDY D05 TPGTF DBSDF TPPTY DSECF 8601 SRHBF TPM NFLX DSEEY SRHBY

16
StarHub Shares Seen Bottoming Out Just as Incoming CEO Steps Up - Bloomberg

2018-07-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DBSDY D05 TPGTF DBSDF TPPTY DSECF 8601 SRHBF TPM NFLX DSEEY SRHBY

21
Japan's MUFG calls on Morgan Stanley expertise in wealth management drive

2018-07-02 reuters
TOKYO (Reuters) - Mitsubishi UFJ Financial Group Inc (MUFG) is drawing on the expertise of U.S. peer Morgan Stanley to help expand in the wealth management business, the head of the pair’s Japanese joint venture told Reuters.
NMR MS.PRE DSECF MS.PRF MS.PRG MS.PRA MS.PRI 8604 N33 MS.PRK 8306 NRSCF MUFG 8601 DSEEY MS MBFJF MTU

209
China Opens Up More of Its Economy to Foreign Investors - Bloomberg

2018-06-30 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
C.WSA IFK XOM GS.PRB GS.PRA BP RDSB RDSA HSB GLSSP UBS.PRDCL 8601 DSEEY JBK TFG BP.A HCS BP.B AAIGF GS.PRJ GS.PRI BP GS.PRD CGBBW GS.PRC RYDBF GS.PRN GS.PRK GS C.WS.B UBS C.WS.A C.PRP C.PRU RYDAF HSBC.PRA HSBC HBCYF C.PRS HCS.PRB RDS.B RDS.A C.PRL IFX C GSC GS.PRICL C.PRJ C.PRK DSECF C.PRG GSJ C.PRC 0005 C.PRPCL HSEA HSEB AAGIY BPAQF GJS ULSGF

57
In One of the World’s Richest Countries, Most Single Mothers Live in Poverty - Bloomberg

2018-06-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK 9681 GS.PRICL GSC TFG GS.PRB DSECF GS.PRA GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC 8601 DSEEY GJS GS.PRN GS.PRK

9
Japanese financial giants: PH samurai bonds to make a killing

2018-06-20 business.inquirer.net
Five large Japanese financial institutions are supporting the Philippines’ upcoming $1-billion samurai bond sale, the first issuance without a guarantee.
NMR 8604 N33 8306 NRSCF DSECF MUFG 8601 DSEEY MBFJF MTU

9
Banks see strong demand for PHL ‘samurai’ bonds

2018-06-20 bworldonline
TOP JAPANESE banks has expressed their interest in participating in the Philippines’ return to the yen debt market following a meeting with the Finance department in Tokyo.
MZHOF NMR DSECF 8604 N33 8306 NRSCF MUFG 8601 8411 DSEEY MBFJF MTU MFG

9
Top Japanese banks express support of Philippine “samurai bonds” following DoF meeting

2018-06-20 bworldonline
TOP JAPANESE BANKS have expressed their interest in participating in the Philippines’ return to the yen debt market following their meeting with the Finance department in Tokyo.
MZHOF NMR DSECF 8604 N33 8306 NRSCF MUFG 8601 8411 DSEEY MBFJF MTU MFG

17
Mercari’s top-of-range IPO set to make founder Shintaro Yamada a new Japanese billionaire

2018-06-11 japantimes.co.jp
Mercari Inc. priced its initial public offering at the top of the range to sell ¥130.5 billion ($1.2 billion) worth of shares, a valuation that’s set to make its 40-year-old founder a billionaire.
NMR MZHOF DSECF SMFG SMFNF YAHOF ZNGA 8604 N33 8316 8306 NRSCF 4689 MUFG 8601 YAHOY 8411 DSEEY MBFJF MTU MFG LN

2
China Harmonizes Booming Gas Market With Residential Price Hike - Bloomberg

2018-05-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CGHLY CGASY DSECF 8601 DSEEY CGHOF 0384

7
Line, Marui and KDDI look for slice of the securities industry

2018-05-16 japantimes.co.jp
Companies in telecommunications, retail and other sectors are entering the securities industry in Japan, aiming to provide young people with financial services that can be conveniently used with credit cards or smartphones.
NMR 8604 N33 NRSCF DSECF 8601 DSEEY KDDIF LN KDDIY

2
Daiwa Securities Group, Inc. ADR 2017 Q4 - Results - Earnings Call Slides

2018-04-27 seekingalpha
The following slide deck was published by Daiwa Securities Group, Inc. ADR in conjunction with their 2017 Q4 earnings call.
DSECF 8601 DSEEY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

8h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

9h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 234064202